The Russian Competition Authority confirms that the pharmaceutical company with a dominant position in the wholesale of certain generics ceased its problematic behavior and signed a contract for medicine supply (Ipsen / Biotek)

Ipsen Company Comply With the Warning of the FAS Russia* Pharmaceutical company made required amendments to the Commercial policy and signed a contract with a distributor to supply their products FAS Russia received a

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteur

Citation

Russian Competition Authority, The Russian Competition Authority confirms that the pharmaceutical company with a dominant position in the wholesale of certain generics ceased its problematic behavior and signed a contract for medicine supply (Ipsen / Biotek), 9 novembre 2020, e-Competitions November 2020, Art. N° 97866

Visites 153

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues